Key facts
- This page summarizes Daniel J. Becker's Form 4 filing for Day One Biopharmaceuticals, Inc. (DAWN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Jun 2021, 21:50.
Daniel J. Becker - 01 Jun 2021 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)
- Reporting relationship
- Director
- Issuer ticker
- DAWN
- Reported as of
- 01 Jun 2021
- Net transaction value
- +$80,000
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2021, 21:50:31 UTC
- Prior SEC filing
- 26 May 2021
- Next SEC filing
- 23 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Charles N. York, II, as Attorney-in-Fact for Reporting Person
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel J. Becker filed Form 4 for Day One Biopharmaceuticals, Inc. (DAWN) on 01 Jun 2021.
Change
- Previous filing in this sequence was filed on 26 May 2021.
- Current net transaction value: +$80,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DAWN
transaction
Common Stock
Purchase
- Transaction value
- $80,000
- Shares
- +5,000
- Change %
- Price
- $16.00
- Shares after
- 5,000
- Date
- 01 Jun 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DAWN
transaction
Derivative
Stock Option (right to buy Common Stock)
Award
- Transaction value
- $0
- Shares
- +63,000
- Change %
- Price
- $0.000000
- Shares after
- 63,000
- Date
- 26 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 63,000
- Exercise price
- $16.00
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The option vests as to 1/36th of the total shares on each monthly anniversary, beginning on June 26, 2021, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Footnote F2
The Reporting Person is reporting the acquisition of these securities pursuant to Rule 16a-2(a) of the Exchange Act.